FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS. February 15, 2018

Similar documents
Zoetis Announces Second Quarter 2018 Results

Zoetis Reports Fourth Quarter and Full Year 2016 Results

Zoetis Announces Third Quarter 2018 Results

Q Financial Supplement

Teradyne, Inc. Certain Non-GAAP financial measures discussed during the Third Quarter of 2011 Earnings Conference Call October 2011

Phibro Animal Health Corporation

Q2 FY2018 Earnings Call. GAAP to non-gaap Reconciliations. May 17, 2018 EXTERNAL USE

July 24, Q Supplemental Information

Q2 13 FINANCIAL HIGHLIGHTS

February 7, Q4 & Full Year 2017 Supplemental Information

FAIR ISAAC CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited)

FAIR ISAAC CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited)

Third Quarter Earnings Release. October 25, 2017

Q Investor Highlights. May 8, 2018

FAIR ISAAC CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited)

FAIR ISAAC CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited)

CSG SYSTEMS INTERNATIONAL, INC. DISCLOSURES FOR NON-GAAP FINANCIAL MEASURES

First Quarter Earnings Release April 25, 2018

Reconciliations of Non-GAAP Financial Measures to the Comparable GAAP Financial Measures (Unaudited) (Dollars in millions, except per share amounts)

AMG ADVANCED METALLURGICAL GROUP N.V. REPORTS RECORD FULL YEAR AND FOURTH QUARTER 2018 RESULTS

Reconciliation of Non-GAAP Items Required by SEC Rules

Bottomline Technologies Reconciliation to Non GAAP Measures Three Months Ended June 30, 2013

CMS ENERGY CORPORATION Earnings Per Share By Year GAAP Reconciliation (Unaudited)

Q3 Fiscal Year 2019 Financial Highlights

Q1 14 FINANCIAL HIGHLIGHTS. April 15, 2014

October 24, Q Supplemental Information

Reconciliation of Non-GAAP Items Required by SEC Rules

Reconciliation of Non-GAAP Items

Q1 Fiscal Year 2019 Financial Highlights

April 26, Q Supplemental Information

Walgreens Boots Alliance Reports Fiscal 2019 First Quarter Results Delivers Double Digit Percentage Growth in Earnings Per Share (EPS)

2Q 2017 Earnings Presentation. August 8, 2017

Q Investor Highlights. August 8, 2018

ZOETIS TO ACQUIRE ABAXIS. May 16, 2018

Second Quarter 2017 Earnings Conference Call August 2, 2017

FY 2019 First Quarter Earnings Call

Third Quarter Fiscal 2019 Earnings Call

FY 2019 FIRST QUARTER EARNINGS. Adient reports first quarter 2019 financial results

Q Earnings Presentation

International Paper Company. Reconciliation of Non-GAAP Financial Measures

SUPPLEMENTAL INFORMATION FIRST-QUARTER 2018

FY 2017 Third Quarter Earnings Call

CMS ENERGY CORPORATION Reconciliation of Non-GAAP FFO to Average Debt Ratio (Unaudited)

Fiscal 2017 ADP Earnings Call & Webcast. July 27, 2017

FY 2018 Third Quarter Earnings Call

Q Financial Results

Walgreens Boots Alliance Reports Fourth Quarter and Fiscal 2017 Results

(24.2) (20.1) Other income (expense), net 3.1 (2.1 ) Consolidated income from operations before income taxes Provision for income taxes

Fourth Quarter Earnings Release. February 1, 2017

CDW Corporation. Webcast Conference Call February, CDW.com

First Quarter 2018 Earnings Presentation

SUPPLEMENTAL INFORMATION THIRD-QUARTER 2018

2016 INVESTOR MEETINGS FIRST QUARTER 2016 WHIRLPOOL CORPORATION

GCP Applied Technologies

ITRON, INC. CONSOLIDATED STATEMENTS OF OPERATIONS

ITRON, INC. CONSOLIDATED STATEMENTS OF OPERATIONS

ITRON, INC. CONSOLIDATED STATEMENTS OF OPERATIONS

ITRON, INC. CONSOLIDATED STATEMENTS OF OPERATIONS

Web.com Reports Fourth Quarter and Full Year 2017 Financial Results

ev3 Inc. NON-GAAP FINANCIAL MEASURES

Fourth Quarter 2010 Earnings Teleconference. February 1, 2011

CBRE GROUP, INC. REPORTS DOUBLE-DIGIT SECOND-QUARTER 2018 REVENUE AND EARNINGS GROWTH AND INCREASES FULL-YEAR OUTLOOK

ITRON, INC. CONSOLIDATED STATEMENTS OF OPERATIONS

ITRON, INC. CONSOLIDATED STATEMENTS OF OPERATIONS

ITRON, INC. CONSOLIDATED STATEMENTS OF OPERATIONS

Q Earnings. GAAP to Non-GAAP Reconciliation

Walgreens Boots Alliance Reports Fiscal 2017 First Quarter Results

Fiscal 2017 First Quarter Results. 5 January 2017

Mattel, Inc. Earnings Conference Call Third Quarter 2016 (Unaudited Results)

Second Quarter 2018 Financial Results. July 31, 2018

Eastman Announces First-Quarter 2017 Financial Results

W. R. Grace & Co. Fourth Quarter 2014 Business Update. Investor Presentation February 5, 2015

Financial results for Q January 26, 2017

1Q Fiscal 2018 ADP Earnings Call & Webcast. November 2, 2017

Eastman Announces Third-Quarter 2018 Financial Results

Reconciliation of Non-GAAP Measures

Q Earnings. GAAP to Non-GAAP

Fourth Quarter and Fiscal 2016 Results. 20 October 2016

Itron, Inc. Comparison of Key 2015 Financial Metrics to Preliminary Results Announced February 17, Total operating expenses 486, ,839

Fourth Quarter Results Fiscal Year 2018

Fourth Quarter 2017 Earnings Presentation

3Q 2018 Highlights and Operating Results. Products. Technology. Services. Delivered Globally.

Polyolefin Catalysts Acquisition

Walgreens Boots Alliance Reports Fiscal 2018 Third Quarter Results

First Quarter 2018 Earnings Teleconference

Pentair Reports Third Quarter 2015 Results

Web.com Reports Fourth Quarter and Full Year 2009 Financial Results

FY 2018 THIRD QUARTER EARNINGS. Adient reports third quarter 2018 financial results

Eastman Announces Fourth-Quarter and Full-Year 2018 Financial Results

Waste Management Announces Fourth Quarter and Full-Year 2012 Earnings

Walgreens Boots Alliance Reports Fiscal 2018 First Quarter Results

CORNING INCORPORATED AND SUBSIDIARY COMPANIES CONSOLIDATED STATEMENTS OF INCOME (Unaudited; in millions, except per share amounts)

Q Financial Results

Mylan Q Non-GAAP Reconciliations November 5, Q Earnings All Results are Unaudited

Q Financial Results

3Q 2017 Earnings Presentation. November 9, 2017

Waste Management Announces First Quarter Earnings

Fourth Quarter 2018 Financial Results

The Chemours Company. Quarterly Financial Information. May 4, 2018

4Q 2018 Highlights and Operating Results. Products. Technology. Services. Delivered Globally.

Transcription:

FOURTH QUARTER AND FULL YEAR 07 FINANCIAL RESULTS February 5, 08

FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements, which reflect the current views of Zoetis with respect to business plans or prospects, future operating or financial performance, future guidance, future operating models, expectations regarding products, future use of cash and dividend payments, tax rate and tax regimes, changes in the tax regimes and laws in other jurisdictions, and other future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our most recent Annual Report on Form 0-K, including in the sections thereof captioned Forward-Looking Statements and Factors That May Affect Future Results and Item A. Risk Factors, in our Quarterly Reports on Form 0-Q and in our Current Reports on Form 8-K. These filings and subsequent filings are available online at www.sec.gov, www.zoetis.com, or on request from Zoetis. NON-GAAP FINANCIAL INFORMATION We use non-gaap financial measures, such as adjusted net income, adjusted diluted earnings per share, and operational results (which excludes the impact of foreign exchange) to assess and analyze our results and trends and to make financial and operational decisions. We believe these non-gaap financial measures are also useful to investors because they provide greater transparency regarding our operating performance. The non-gaap financial measures included in this presentation should not be considered alternatives to measurements required by GAAP, such as net income, operating income, and earnings per share, and should not be considered measures of liquidity. These non-gaap financial measures are unlikely to be comparable with non-gaap information provided by other companies. Reconciliation of non-gaap financial measures and GAAP financial measures are included in the tables accompanying our earnings release and are posted on our website at www.zoetis.com.

JUAN RAMÓN ALAIX CHIEF EXECUTIVE OFFICER 3 3

KEY CEO TAKEAWAYS STRONG FULL-YEAR 07 RESULTS Delivered operational growth of 8% in revenue and % in adjusted net income, in-line with Zoetis long-term value proposition to shareholders Diverse portfolio drove solid revenue performance across all species and key markets, with strong operational growth of 4% in companion animal products leading the way Almost doubled operating cash flow compared to 06 due to income growth and our increased discipline on the balance sheet Became first animal health company to achieve more than $5 billion in annual revenue POSITIVE OUTLOOK FOR LONG TERM PROFITABLE GROWTH Established full year 08 guidance with adjusted net income growing faster than revenue on an operational basis Will continue investing in critical commercial, manufacturing, and R&D capabilities, as well as business development opportunities, to sustain long-term growth 4 Increased cash flow and recent U.S. tax change provide greater funding and flexibility for growth investments 4 Operational growth (a non-gaap financial measure) excludes the impact of foreign exchange Adjusted Net Income (non-gaap financial measure) and adjusted diluted earnings per share are defined as reported U.S. generally accepted accounting principles (GAAP) net income excluding purchase accounting adjustments, acquisition-related costs and certain significant items

GLENN DAVID CHIEF FINANCIAL OFFICER 5 5

INCOME STATEMENT HIGHLIGHTS Fourth Quarter 07 * 06 * Change Revenue $,460 $,77 4% Reported Net Income 8 54 (47)% Reported Diluted Earnings Per Share $0.6 $0.3 (48)% Adjusted Net Income 34 3 47% Adjusted Diluted EPS $0.69 $0.47 47% * Millions of dollars, except per share data 6 Adjusted net income and adjusted diluted earnings per share (non-gaap financial measures) are defined as reported net income attributable to Zoetis and reported diluted earnings per share, excluding purchase accounting adjustments, acquisition-related costs and certain significant items. 6

INCOME STATEMENT HIGHLIGHTS Full Year 07 * 06 * Change Revenue $5,307 $4,888 9% Reported Net Income 864 8 5% Reported Diluted Earnings Per Share $.75 $.65 6% Adjusted Net Income,85 975 % Adjusted Diluted EPS $.40 $.96 % * Millions of dollars, except per share data 7 Adjusted net income and adjusted diluted earnings per share (non-gaap financial measures) are defined as reported net income attributable to Zoetis and reported diluted earnings per share, excluding purchase accounting adjustments, acquisition-related costs and certain significant items. 7

ADJUSTED INCOME STATEMENT HIGHLIGHTS * Millions of dollars NA 8 Not applicable Fourth Quarter 07* 06* Change Foreign Exchange Operational Revenue $,460 $,77 4% % 3% Adjusted Cost of Sales 454 455 - % ()% as a percent of revenue 3.% 35.6% NA NA NA Adjusted SG&A Expenses 359 348 3% % % Adjusted R&D Expenses 0 07 3% % % Effective Tax Rate on Adjusted Income 7.5% 5.% NA NA NA Adjusted Net Income 34 3 47% 0% 37% 8 Adjusted net income and its components and adjusted diluted EPS (non-gaap financial measures) are defined as reported U.S. generally accepted accounting principles (GAAP) net income and its components and reported diluted EPS excluding purchase accounting adjustments, acquisition-related costs and certain significant items. Adjusted cost of sales, adjusted selling, general and administrative (SG&A) expenses, adjusted research and development (R&D) expenses, and adjusted tax expenses are income statement line items prepared on the same basis, and, therefore, components of the overall adjusted income measure. Operational growth (a non-gaap financial measure) excludes the impact of foreign exchange.

ADJUSTED INCOME STATEMENT HIGHLIGHTS * Millions of dollars NA 9 Not applicable Full Year 07* 06* Change Foreign Exchange Operational Revenue $5,307 $4,888 9% % 8% Adjusted Cost of Sales,76,64 8% % 7% as a percent of revenue 33.% 33.% NA NA NA Adjusted SG&A Expenses,35,3 % - % Adjusted R&D Expenses 380 374 % % % Effective Tax Rate on Adjusted Income 8.% 9.9% NA NA NA Adjusted Net Income,85 975 % % % 9 Adjusted net income and its components and adjusted diluted EPS (non-gaap financial measures) are defined as reported U.S. generally accepted accounting principles (GAAP) net income and its components and reported diluted EPS excluding purchase accounting adjustments, acquisition-related costs and certain significant items. Adjusted cost of sales, adjusted selling, general and administrative (SG&A) expenses, adjusted research and development (R&D) expenses, and adjusted tax expenses are income statement line items prepared on the same basis, and, therefore, components of the overall adjusted income measure. Operational growth (a non-gaap financial measure) excludes the impact of foreign exchange.

US SEGMENT PERFORMANCE 0 Fourth Quarter 07* 06* Change Foreign Exchange Operational Revenue $7 $63 3% - 3% Livestock 374 336 % - % Companion Animal 338 95 5% - 5% Cost of Sales 53 49 3% - 3% Gross Profit 559 48 6% - 6% Gross Margin 78.5% 76.4% NA - NA Operating Expenses 09 95 5% - 5% Other (Income)/Deductions (3) - ** - ** Earnings 453 387 7% - 7% * Millions of dollars, NA Not applicable, ** Calculation not meaningful 0 Operational growth (a non-gaap financial measure) excludes the impact of foreign exchange Defined as income before provision for taxes on income

US SEGMENT PERFORMANCE Full Year 07* 06* Change Foreign Exchange Operational Revenue $,60 $,447 7% - 7% Livestock,44,7 % - % Companion Animal,376,0 3% - 3% Cost of Sales 565 55 3% - 3% Gross Profit,055,896 8% - 8% Gross Margin 78.4% 77.5% NA - NA Operating Expenses 4 388 9% - 9% Other (Income)/Deductions (3) - ** - ** Earnings,637,508 9% - 9% * Millions of dollars, NA Not applicable, ** Calculation not meaningful Operational growth (a non-gaap financial measure) excludes the impact of foreign exchange Defined as income before provision for taxes on income

INTERNATIONAL SEGMENT PERFORMANCE * Millions of dollars, NA Not applicable Fourth Quarter 07* 06* Change Foreign Exchange Operational Revenue $740 $636 6% 3% 3% Livestock 57 454 4% 3% % Companion Animal 3 8 3% 5% 8% Cost of Sales 44 35 4% 3% % Gross Profit 496 40 4% 4% 0% Gross Margin 67.0% 63.% NA NA NA Operating Expenses 43 40 % 3% ()% Other (Income)/Deductions - () (00)% (30)% (70)% Earnings 353 6 35% 4% 3% Operational growth (a non-gaap financial measure) excludes the impact of foreign exchange Defined as income before provision for taxes on income

INTERNATIONAL SEGMENT PERFORMANCE 3 * Millions of dollars, NA Not applicable, ** Calculation not meaningful Full Year 07* 06* Change Foreign Exchange Operational Revenue $,643 $,390 % % 0% Livestock,793,654 8% % 7% Companion Animal 850 736 5% ()% 6% Cost of Sales 889 833 7% % 6% Gross Profit,754,557 3% % % Gross Margin 66.4% 65.% NA NA NA Operating Expenses 55 50 3% % % Other (Income)/Deductions () ** ** ** Earnings,40,054 8% % 7% 3 Operational growth (a non-gaap financial measure) excludes the impact of foreign exchange Defined as income before provision for taxes on income

INTERNATIONAL MARKET REVENUE Fourth Quarter 07* 06* Change Foreign Exchange Operational Total International $740 $636 6% 3% 3% Australia 4 38 % 5% 6% Brazil 95 83 4% % 3% Canada 6 53 5% 6% 9% China 37 3 6% 3% 3% France 36 8 9% 6% 3% Germany 4 35 7% 6% % Italy 4 0 0% 0% 0% Japan 37 3 9% (8)% 7% Mexico 6 0 30% 0% 0% Spain 6 0 30% 3% 7% United Kingdom 44 39 3% 5% 8% Other Developed 99 79 5% 3% % Other 4 Emerging 7 58 9% % 8% * Millions of dollars 4 Operational growth (a non-gaap financial measure) excludes the impact of foreign exchange.

INTERNATIONAL MARKET REVENUE Full Year 07* 06* Change Foreign Exchange Operational Total International $,643 $,390 % % 0% Australia 76 57 % 3% 9% Brazil 300 45 % 0% % Canada 84 73 6% % 5% China 74 45 0% (4)% 4% France 7 3% - 3% Germany 37 5 0% % 9% Italy 89 83 7% % 6% Japan 38 7 9% (3)% % Mexico 86 76 3% (3)% 6% Spain 93 8 3% % % United Kingdom 49 5 ()% (7)% 6% Other Developed 339 30 % % % Other 5 Emerging 657 607 8% ()% 9% * Millions of dollars 5 Operational growth (a non-gaap financial measure) excludes the impact of foreign exchange.

FINANCIAL GUIDANCE Selected Line Items (millions of dollars, except per share amounts) Full Year 08 $5,675 to $5,800 $,450 to,50 Revenue Operational growth 5% to 7% Adjusted cost of sales as a percentage of revenue Approximately 3% Adjusted SG&A expenses $,370 to $,40 Adjusted R&D expenses $400 to $40 Adjusted interest expense and other (income) / deductions Approximately $90 Effective tax rate on adjusted income % - % Adjusted diluted EPS $.96 to $3.0 Adjusted net income Operational growth,3 0% to 6% Certain significant items 4 and acquisition-related costs $0 to $40 Reported diluted EPS $.77 to $.93 6 Operational growth (a non-gaap financial measure) excludes the impact of foreign exchange Adjusted net income and its components and adjusted diluted EPS (non-gaap financial measures) are defined as reported U.S. generally accepted accounting principles (GAAP) net income and its components and reported diluted EPS excluding purchase 6 accounting adjustments, acquisition-related costs and certain significant items. Adjusted cost of sales, adjusted SG&A expenses, adjusted R&D expenses, adjusted interest expense, and adjusted other (income)/deductions are income statement line items prepared on the same basis, and, therefore, components of the overall adjusted income measure. Adjusted net income and its components and adjusted diluted EPS are presented solely to permit investors to more fully understand how management assesses performance. Adjusted net income and its components and adjusted diluted EPS are not, and should not be viewed as, substitutes for U.S. GAAP net income and its components and diluted EPS. 3 We do not provide a reconciliation of forward-looking non-gaap adjusted net income operational growth to the most directly comparable GAAP Reported financial measure because we are unable to calculate with reasonable certainty the foreign exchange impact of unusual gains and losses, acquisition-related expenses, potential future asset impairments and other certain significant items, without unreasonable effort. The foreign exchange impact of these items are uncertain, depend on various factors, and could have a material impact on GAAP Reported results for the guidance period. 4 Primarily includes certain nonrecurring costs related to restructuring and other charges for the supply network strategy. Excludes potential net gains/losses on sales of assets.

Q&A 7 7

APPENDIX 8 8

RECONCILIATION OF GAAP REPORTED TO NON- GAAP ADJUSTED INFORMATION 07 in USD millions GAAP Reported Purchase Accounting Acquisition Related Costs Certain Significant Items Cost of Sales,775 (7) - (7),76 Gross Profit 3,53 7-7 3,546 Non-GAAP Adjusted Gross Profit as % of Revenue 66.6% 66.8% Selling, General and Administrative expenses,334 (5) - (4),35 Research & Development Expenses 38 () - - 380 Amortization of Intangible Assets 9 (74) - - 7 Total Operating Expenses,807 (8) - (4),7 Total Operating Expenses as % of Revenue 34.0% 3.4% Restructuring Charges and Certain Acquisition Related Costs 9 - (0) (9) - Other (Income) / Expenses 6 - - (5) Income before Provision for Taxes on Income,55 88 0 5,648 Provision for Taxes on Income 663 37 3 (38) 465 Income from Continuing Operations 86 5 7 63,83 Net Income attributable to Zoetis 864 5 7 63,85 U.S. generally accepted accounting principles. 9 Non-GAAP adjusted net income and its components are not, and should not be viewed as, substitutes for U.S. GAAP net income and its components. Non-GAAP adjusted net income and its components are presented solely to permit investors to more fully understand how management assesses performance. 9

RECONCILIATION OF GAAP REPORTED TO NON- GAAP ADJUSTED INFORMATION 06 in USD millions GAAP Reported Purchase Accounting Acquisition Related Costs Certain Significant Items Cost of Sales,666 (3) - (9),64 Gross Profit 3, 3-9 3,64 Non-GAAP Adjusted Gross Profit as % of Revenue 65.9% 66.8% Selling, General and Administrative expenses,364 (5) - (47),3 Research & Development Expenses 376 () - - 374 Amortization of Intangible Assets 85 (69) - - 6 Total Operating Expenses,85 (76) - (47),70 Total Operating Expenses as % of Revenue 37.3% 34.8% Restructuring Charges and Certain Acquisition Related Costs 5 - (3) () - Other (Income) / Expenses () - () 8 Income before Provision for Taxes on Income,8 99 4 57,388 Provision for Taxes on Income 409 39 - (33) 45 Income from Continuing Operations 89 60 4 90 973 Net Income attributable to Zoetis 8 60 4 90 975 U.S. generally accepted accounting principles. 0 Non-GAAP adjusted net income and its components are not, and should not be viewed as, substitutes for U.S. GAAP net income and its components. Non-GAAP adjusted net income and its components are presented solely to permit investors to more fully understand how management assesses performance. 0

RECONCILIATION OF GAAP REPORTED TO NON- GAAP ADJUSTED INFORMATION 05 in USD millions GAAP Reported Purchase Accounting Acquisition Related Costs Certain Significant Items Cost of Sales,738 (9) - (6),667 Gross Profit 3,07 9-6 3,098 Non-GAAP Adjusted Gross Profit as % of Revenue 63.5% 65.0% Selling, General and Administrative expenses,53 - - (33),399 Research & Development Expenses 364 () - () 360 Amortization of Intangible Assets 6 (46) - - 5 Total Operating Expenses,957 (48) - (35),774 Total Operating Expenses as % of Revenue 4.% 37.% Restructuring Charges and Certain Acquisition Related Costs 30 - (9) (30) - Other (Income) / Expenses 8 - () (94) (5) Income before Provision for Taxes on Income 545 57 59,5 Provision for Taxes on Income 06 8 () 03 36 Income from Continuing Operations 339 39 489 889 Net Income attributable to Zoetis 339 39 489 889 U.S. generally accepted accounting principles. Non-GAAP adjusted net income and its components are not, and should not be viewed as, substitutes for U.S. GAAP net income and its components. Non-GAAP adjusted net income and its components are presented solely to permit investors to more fully understand how management assesses performance.

RECONCILIATION OF GAAP REPORTED TO NON- GAAP ADJUSTED INFORMATION 04 in USD millions GAAP Reported Purchase Accounting Acquisition Related Costs Certain Significant Items Cost of Sales,77 (4) - (33),680 Gross Profit 3,068 4-33 3,05 Non-GAAP Adjusted Gross Profit as % of Revenue 64.% 64.9% Selling, General and Administrative expenses,643 - - (36),507 Research & Development Expenses 396 () - () 393 Amortization of Intangible Assets 60 (45) - - 5 Total Operating Expenses,099 (47) - (37),95 Total Operating Expenses as % of Revenue 43.9% 40.0% Restructuring Charges and Certain Acquisition Related Costs 5 - (8) (7) - Other (Income) / Expenses 7 - - (8) () Income before Provision for Taxes on Income 80 5 8 05,084 Provision for Taxes on Income 33 7 3 37 90 Income from Continuing Operations 587 34 5 68 794 Net Income attributable to Zoetis 583 34 5 68 790 U.S. generally accepted accounting principles. Non-GAAP adjusted net income and its components are not, and should not be viewed as, substitutes for U.S. GAAP net income and its components. Non-GAAP adjusted net income and its components are presented solely to permit investors to more fully understand how management assesses performance.

RECONCILIATION OF GAAP REPORTED TO NON- GAAP ADJUSTED INFORMATION 03 in USD millions GAAP Reported Purchase Accounting Acquisition Related Costs Certain Significant Items Cost of Sales,669 () - (4),65 Gross Profit,89-4,936 Non-GAAP Adjusted Gross Profit as % of Revenue 63.4% 64.4% Selling, General and Administrative expenses,63 - (88),46 Research & Development Expenses 399 () - (7) 39 Amortization of Intangible Assets 60 (46) - - 4 Total Operating Expenses,07 (46) - (95),83 Total Operating Expenses as % of Revenue 45.4% 40.% Restructuring Charges and Certain Acquisition Related Costs 6 - () (4) - Other (Income) / Expenses (9) - - (8) Income before Provision for Taxes on Income 690 48 40,000 Provision for Taxes on Income 87 6 8 8 9 Income from Continuing Operations 503 3 4 59 708 Net Income attributable to Zoetis 504 3 4 59 709 U.S. generally accepted accounting principles. 3 Non-GAAP adjusted net income and its components are not, and should not be viewed as, substitutes for U.S. GAAP net income and its components. Non-GAAP adjusted net income and its components are presented solely to permit investors to more fully understand how management assesses performance. 3

RECONCILIATION OF ADJUSTED NET INCOME TO ADJUSTED EBIT 03 07 in USD millions 03 04 05 06 07 Adjusted Net Income Before Allocation to Noncontrolling $708 $794 $889 $973 $,83 Interests 3 Interest Expense 4 3 7 4 66 75 Interest Income 4 (3) (6) (6) (8) (3) Income Taxes 4 9 90 36 45 465 Adjusted EBIT 5 $,0 $,95 $,333 $,546 $,80 % of revenue 4.3% 5.0% 8.0% 3.6% 34.% 3 Adjusted Net Income Before Allocation to Noncontrolling Interests (a non-gaap financial measure) is defined as the corresponding reported U.S. generally accepted accounting principles (GAAP) income statement line item, excluding purchase accounting adjustments, acquisition-related costs and certain significant items. The adjusted net income measure is not, and should not be viewed as, a substitute for U.S. GAAP reported net income attributable to Zoetis. 4 4 As included in adjusted net income. 5 Adjusted Earnings Before Interest and Taxes (EBIT) (a non-gaap financial measure) is calculated before the impact of purchase accounting adjustments, acquisitionrelated costs and certain significant items and is a non-gaap financial measure. 4